Amylyx Pharmaceuticals
AMLX
#6929
Rank
A$0.69 B
Marketcap
$7.79
Share price
-6.53%
Change (1 day)
167.63%
Change (1 year)

Amylyx Pharmaceuticals (AMLX) - Cash on Hand

Cash on Hand as of December 2024 : A$0.27 Billion

According to Amylyx Pharmaceuticals's latest financial reports the company has A$0.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Amylyx Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.28 B-47.94%
2023-12-31A$0.54 B6.91%
2022-12-31A$0.50 B284.55%
2021-12-31A$0.13 B691.68%
2020-12-31A$16.74 M282.55%
2019-12-31A$4.37 M